PRECLINICAL MECHANISTIC INVESTIGATION OF THE FIRST-IN-CLASS SIK2/SIK3 INHIBITOR GLPG3970 IN AN EXPERIMENTAL MODEL OF IBD
Stéphanie Lavazais 1
Adrien Cosson 1
Didier Merciris 1
Carole Delachaume 1
Laetitia Perret 1
Anne Gigout 1
Nicolas Desroy 1
David AMANTINI 1
Steve De Vos 2
1 Galapagos SASU, Romainville, France
2 Galapagos NV, Mechelen, Belgium
Topic
Disease Mechanisms, IBD, Immunology
Session
Basic science in IBD
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]